COMPOSITIONS AND METHODS FOR ENHANCED TUMOR CELL IMMUNITY IN VIVO

Patent №

US 5,772,995

Granted

1998-06-30

Filed 1994

Owner

SAN DIEGO REGIONAL CANCER CENTER 3099 SCIENCE PARK ROAD, STE 200

+3 more

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

08276694

The invention provides a method of preventing or reducing the severity of a cancer in a subject by stimulating the subject's immune response against the cancer. The invention provides, for example, a method of stimulating an immune response in a subject by administering to the subject tumor cells that are substantially similar to the subject's cancer cells and that are genetically modified to reduce or inhibit the expression of one or more immunosuppressive agents. The invention also provides a method of preventing or reducing the severity of cancer in a subject by stimulating the subject's immune response against the cancer by administering to the subject tumor cells that are substantially similar to the subject's cancer cells and that are genetically modified to prevent the expression of an immunosuppressive agents and, in combination with the genetically modified tumor cells, an immunostimulatory agent. The invention further provides compositions useful for practicing the claimed methods.

AI hardwareC12N 15/1136A61P 35/00A61P 37/04C07K 14/495A61K 38/00A61K 48/00C12N 2799/027

AI classification

AI hardware0.59
Evolutionary computation0.00
Natural language0.00
Vision0.00
Machine learning0.00
Knowledge representation0.00
Speech0.00
Planning0.00

Ownership

SAN DIEGO REGIONAL CANCER CENTER 3099 SCIENCE PARK ROAD, STE 200

assignment · 71570210

SYDNEY KIMMEL CANCER CENTER

assignment · 75690939

SIDNEY KIMMEL CANCER CENTER

correct · 77830635

NOVARX, INC.

assignment · 261050424

Assignors

FAKHRAI, HABIB, DORIGO, OLIVER, SOBOL, ROBERT E.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC